Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.